Monthly Drifts in Nexalin Technology Inc (NXL) Stock: A Closer Look

Nora Barnes

Nexalin Technology Inc [NXL] stock prices are up 14.29% to $1.52 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The NXL shares have gain 18.75% over the last week, with a monthly amount glided 92.53%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

The stock price of Nexalin Technology Inc [NXL] has been fluctuating between $0.70 and $4.49 over the past year. Nexalin Technology Inc [NASDAQ: NXL] shares were valued at $1.52 at the most recent close of the market.

Analyzing the NXL fundamentals

The Nexalin Technology Inc [NASDAQ:NXL] reported sales of 0.17M for trailing twelve months, representing a surge of 163.00%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -51.58%, Pretax Profit Margin comes in at -50.65%, and Net Profit Margin reading is -50.63%. To continue investigating profitability, this company’s Return on Assets is posted at -1.35, Equity is -2.09 and Total Capital is -1.51.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3825 points at the first support level, and at 1.2451 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5937, and for the 2nd resistance point, it is at 1.6675.

Ratios To Look Out For

It’s worth pointing out that Nexalin Technology Inc [NASDAQ:NXL]’s Current Ratio is 10.44. On the other hand, the Quick Ratio is 10.15, and the Cash Ratio is 0.72. Considering the valuation of this stock, the price to sales ratio is 162.65, the price to book ratio is 4.44.

Transactions by insiders

Recent insider trading involved Elson Marilyn, Associate to Affiliate, that happened on Sep 10 ’25 when 23150.0 shares were purchased. Sr. VP – Quality, Regulatory, Shelton Carolyn Hamby completed a deal on Mar 12 ’25 to buy 6000.0 shares. Meanwhile, Chief Medical Officer Owens David bought 1000.0 shares on Feb 04 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.